Dixon Hubard Feinour & Brown’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $7M | Buy |
76,828
+3,063
| +4% | +$272K | 0.83% | 41 |
|
|
2022
Q1 | $6.05M | Buy |
73,765
+624
| +0.9% | +$49.2K | 0.61% | 46 |
|
|
2021
Q4 | $5.61M | Buy |
73,141
+55,650
| +318% | +$4.43M | 0.54% | 55 |
|
|
2021
Q3 | $1.31M | Sell |
17,491
-1,733
| -9% | -$132K | 0.28% | 71 |
|
|
2021
Q2 | $1.5M | Sell |
19,224
-32,790
| -63% | -$2.44M | 0.31% | 69 |
|
|
2021
Q1 | $3.99M | Buy |
52,014
+22,677
| +77% | +$1.67M | 0.49% | 49 |
|
|
2020
Q4 | $2.32M | Hold |
29,337
| – | – | 0.6% | 40 |
|
|
2020
Q3 | $2.32M | Sell |
29,337
-325
| -1% | -$25.5K | 0.6% | 40 |
|
|
2020
Q2 | $2.25M | Sell |
29,662
-503
| -2% | -$37.9K | 0.59% | 39 |
|
|
2020
Q1 | $2.21M | Buy |
30,165
+6,004
| +25% | +$472K | 0.75% | 38 |
|
|
2019
Q4 | $2.1M | Hold |
24,161
| – | – | 0.54% | 45 |
|
|
2019
Q3 | $1.94M | Sell |
24,161
-119
| -0.5% | -$9.54K | 0.54% | 49 |
|
|
2019
Q2 | $1.94M | Buy |
24,280
+545
| +2% | +$41.7K | 0.55% | 48 |
|
|
2019
Q1 | $1.88M | Buy |
23,735
+2,025
| +9% | +$151K | 0.57% | 49 |
|
|
2018
Q4 | $1.58M | Sell |
21,710
-176
| -0.8% | -$12.4K | 0.59% | 49 |
|
|
2018
Q3 | $1.48M | Hold |
21,886
| – | – | 0.41% | 63 |
|
|
2018
Q2 | $1.27M | Sell |
21,886
-2,107
| -9% | -$119K | 0.37% | 66 |
|
|
2018
Q1 | $1.25M | Sell |
23,993
-1,460
| -6% | -$78.9K | 0.35% | 74 |
|
|
2017
Q4 | $1.37M | Buy |
25,453
+1,787
| +8% | +$99.1K | 0.37% | 72 |
|
|
2017
Q3 | $1.45M | Hold |
23,666
| – | – | 0.42% | 68 |
|
|
2017
Q2 | $1.45M | Hold |
23,666
| – | – | 0.42% | 71 |
|
|
2017
Q1 | $1.44M | Buy |
23,666
+1,260
| +6% | +$76.4K | 0.43% | 67 |
|
|
2016
Q4 | $1.26M | Sell |
22,406
-459
| -2% | -$26.9K | 0.4% | 70 |
|
|
2016
Q3 | $1.36M | Buy |
22,865
+681
| +3% | +$39.8K | 0.42% | 64 |
|
|
2016
Q2 | $1.22M | Buy |
22,184
+1,432
| +7% | +$76.2K | 0.39% | 69 |
|
|
2016
Q1 | $1.09M | Sell |
20,752
-1,531
| -7% | -$75K | 0.35% | 78 |
|
|
2015
Q4 | $1.12M | Sell |
22,283
-1,048
| -4% | -$52.8K | 0.36% | 69 |
|
|
2015
Q3 | $1.1M | Sell |
23,331
-1,274
| -5% | -$67.7K | 0.41% | 61 |
|
|
2015
Q2 | $1.34M | Sell |
24,605
-692
| -3% | -$38.8K | 0.41% | 64 |
|
|
2015
Q1 | $1.39M | Buy |
25,297
+2,804
| +12% | +$159K | 0.41% | 65 |
|
|
2014
Q4 | $1.22M | Sell |
22,493
-839
| -4% | -$46.7K | 0.38% | 71 |
|
|
2014
Q3 | $1.32M | Sell |
23,332
-340
| -1% | -$19.1K | 0.43% | 62 |
|
|
2014
Q2 | $1.31M | Hold |
23,672
| – | – | 0.43% | 62 |
|
|
2014
Q1 | $1.28M | Buy |
23,672
+2,512
| +12% | +$130K | 0.44% | 62 |
|
|
2013
Q4 | $1.01M | Sell |
21,160
-760
| -3% | -$34.7K | 0.37% | 68 |
|
|
2013
Q3 | $996K | Sell |
21,920
-210
| -0.9% | -$9.59K | 0.42% | 64 |
|
|
2013
Q2 | $981K | Buy |
+22,130
| New | +$988K | 0.44% | 63 |
|
Other funds holding MRK
Dixon Hubard Feinour & Brown's MRK Position: Q2 2022 in Review
Dixon Hubard Feinour & Brown increased its Merck (MRK) stake by 4.2% in Q2 2022, buying an estimated $272K and bringing the position to 76,828 shares worth $7M. The position accounts for 0.83% of the portfolio, ranked #41.
Dixon Hubard Feinour & Brown first reported a position in MRK in Q2 2013 and has held it in 37 quarters since. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Dixon Hubard Feinour & Brown held 76,828 shares of Merck worth $7M as of Q2 2022.
- Dixon Hubard Feinour & Brown bought 3,063 Merck shares in Q2 2022, an estimated $272K.
- Merck made up 0.83% of Dixon Hubard Feinour & Brown's portfolio in Q2 2022, its #41 holding.
- Dixon Hubard Feinour & Brown first reported a position in Merck in Q2 2013 and has held it in 37 quarters since.
- 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.